validamine: RN given from CA Index Guide; RN not in Chemline 11/84; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
validamine : An amino cyclitol consisting of 1D-chiro-inositol lacking the 6-hydroxy group and having those at positions 1 and 5 replaced by amino and hydroxymethyl groups respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 446685 |
| CHEMBL ID | 1628264 |
| CHEBI ID | 30449 |
| SCHEMBL ID | 5793335 |
| MeSH ID | M0126491 |
| Synonym |
|---|
| AC-4499 |
| d-chiro-inositol, 1-amino-1,5,6-trideoxy-5-(hydroxymethyl)- |
| validamine |
| CHEBI:30449 , |
| 1d-1-amino-1,5,6-trideoxy-5-(hydroxymethyl)-chiro-inositol |
| 32780-32-8 |
| (1r,2s,3s,4s)-4-amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol |
| 1-amino-1,5,6-trideoxy-5-(hydroxymethyl)-d-chiro-inositol |
| (+)-validamine |
| (1r,2s,3s,4s,6r)-4-amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol |
| CHEMBL1628264 , |
| AKOS006284984 |
| A821410 |
| bdbm50367332 |
| SCHEMBL5793335 |
| Q27113564 |
| 4-amino-6-(hydroxymethyl)cyclohexane-1,2,3-triol |
| DTXSID60954439 |
| HY-N2383 |
| CS-0022551 |
| Class | Description |
|---|---|
| amino cyclitol | Any cyclitol having one or more alcoholic hydroxy groups replaced by substituted or unsubstituted amino groups. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | IC50 (µMol) | 110.0000 | 0.0400 | 3.4652 | 9.0000 | AID104666 |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | IC50 (µMol) | 7.5000 | 0.0490 | 2.7294 | 7.8000 | AID208984 |
| Beta-galactosidase | Bos taurus (cattle) | IC50 (µMol) | 1,000.0000 | 1.5000 | 2.7000 | 3.6000 | AID241465 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (7.14%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (92.86%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||